| 米氮平治疗广泛性焦虑症的开放性研究 |
| |
| 引用本文： | 余琳.米氮平治疗广泛性焦虑症的开放性研究[J].中国实用医药,2006,1(2):3-4. |
| |
| 作者姓名： | 余琳 |
| |
| 作者单位： | 河南煤炭卫生学校附属医院,河南,平顶山,467013 |
| |
| 摘 要： | 目的 观察米氮平治疗广泛性焦虑的疗效和安全性.方法 对符合CCMD-3广泛性焦虑诊断标准的患者26例使用30mg/日米氮平治疗6周,在0、2、4、6周评定汉密尔顿焦虑量表(HAMA,14项),并评定疗效、记录出现的不良反应.结果 米氮平能显著改善GAD患者的精神性焦虑和躯体性焦虑,治疗结束时的显效率达67.9%,有效率达92.9%.最常见的不良反应为嗜睡和体重增加.结论 米氮平对广泛性焦虑症疗效肯定,不良反应少.
|
| 关 键 词： | 米氮平 广泛性焦虑症 |
| 文章编号： | 1673-7555[2006]10-3-02 |
Clinical Study of Mirtazapine in the Treatment of Generalized Anxiety Disorder (GAD) |
| |
| YU lin.Clinical Study of Mirtazapine in the Treatment of Generalized Anxiety Disorder (GAD)[J].China Practical Medical,2006,1(2):3-4. |
| |
| Authors: | YU lin |
| |
| Abstract: | Objective To explore the clinical efficacy and side effects of mirtazapine in the treatment of generalized anxiety disorder. Methods 26 patients who met CCMD-3 criteria for generalized anxiety disorder were involved in this study, they were treated with mirtazapine for six weeks. Efficacy and side effects were evaluated with hamilton anxiety scale (HAMA) before and after treatment.Results The efficacy rate of was 88.5%, in which 65.4% were improved markedly. The side effects of mirtazapine were lighter than.Conclusion Mirtazapine is effective in the treatment of generalized anxiety disorder and produces fewer side effects. |
| |
| Keywords: | Generalized anxiety disorder Mirtazapine |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
|
